Tus%2525252525252525252525252525252520qd

# TUSQD (TUS QUINIDINE SULFATE) ## Overview TusQD is a brand name for quinidine sulfate, an antiarrhythmic medication belonging to Class Ia. It functions by prolonging the action potential duration and effective refractory period of atrial and ventricular muscle. ## Primary Indications * Prevention of atrial fibrillation and flutter recurrence. * Maintenance of normal sinus rhythm after cardioversion of atrial fibrillation and flutter. * Treatment of ventricular arrhythmias, including ventricular tachycardia. ## Adult Dosing Dosing is highly individualized and depends on the specific arrhythmia and patient response. Titration is typically required. * **Atrial Fibrillation/Flutter:** Oral doses often range from 200 mg every 6-8 hours to 300-400 mg every 8 hours. Doses may be further adjusted based on ECG and clinical response, with a maximum generally not exceeding 1.6 g per day divided into 3-4 doses. * **Ventricular Arrhythmias:** Oral doses may start at 200-300 mg every 6 hours and titrate upwards. Maximum daily doses are often similar to those for atrial fibrillation. ## Pediatric Dosing Pediatric dosing is not well-established and should be managed by a pediatric cardiologist. Dosing is typically based on weight and clinical response, and careful monitoring is essential. ## Dose Adjustments * **Hepatic Impairment:** Quinidine is extensively metabolized by the liver. Dose reduction may be necessary in patients with significant hepatic dysfunction. * **Renal Impairment:** While quinidine is primarily metabolized, its metabolites are renally excreted. Dose reduction may be needed in severe renal impairment. ## Contraindications * Known hypersensitivity to quinidine. * Myasthenia gravis. * Idiosyncratic reaction to quinine or related compounds (e.g., quinidine, cinchonine). * Complete heart block or other intraventricular conduction defects (e.g., >50% widening of the QRS complex) not controlled by a pacemaker. * Certain cardiac conditions: Sick sinus syndrome, digitalis intoxication, torsades de pointes. ## Adverse Effects Common: Diarrhea, nausea, vomiting, abdominal cramping, headache, dizziness, tinnitus, visual disturbances. Serious: QT prolongation, torsades de pointes, hypotension, syncope, AV block, neutropenia, thrombocytopenia, agranulocytosis, hemolysis, lupus-like syndrome, hepatotoxicity, hypersensitivity reactions (e.g., fever, rash). ## Key Drug Interactions * **CYP3A4 Inhibitors/Inducers:** Quinidine is a substrate of CYP3A4. Inhibitors (e.g., ketoconazole, erythromycin) can increase quinidine levels, while inducers (e.g., rifampin, carbamazepine) can decrease levels. * **Drugs that Prolong QT Interval:** Concomitant use increases the risk of torsades de pointes. * **Warfarin:** Quinidine can significantly increase the anticoagulant effect of warfarin. * **Digoxin:** Quinidine can increase digoxin serum concentrations, leading to toxicity. * **Beta-blockers:** Additive myocardial depressant effects. * **Anticholinergics:** May potentiate anticholinergic effects. ## Monitoring * **ECG:** Regular monitoring for QT interval prolongation, QRS widening, and arrhythmias. * **Blood Pressure:** Especially during titration. * **Electrolytes:** Particularly potassium and magnesium, as imbalances can increase arrhythmogenic risk. * **Renal and Hepatic Function:** To guide dose adjustments. * **Complete Blood Count:** For potential hematologic toxicity. * **Therapeutic Drug Monitoring:** Quinidine serum levels may be monitored, with therapeutic ranges typically between 2-5 mcg/mL, though clinical response is paramount. ## Clinical Pearls * Quinidine can cause "cinchonism" (tinnitus, visual disturbances, headache, nausea) even at therapeutic doses. * It has anticholinergic, alpha-adrenergic blocking, and vagolytic effects that can contribute to adverse events. * Discontinuation of quinidine should be gradual to avoid rebound arrhythmias. * Patients should be advised to report any new or worsening symptoms promptly. *** *Disclaimer: This information is intended for clinical decision support and does not replace professional medical judgment. Always verify current prescribing information, product monographs, and local protocols before initiating or modifying drug therapy.*